INTERFERON-BETA TREATMENT OF HUMAN-DISEASE

被引：16

作者：

ALAM, JJ

机构：

[1] Medical Research Department, Biogen Corporation, 14 Cambridge Center, Cambridge

来源：

CURRENT OPINION IN BIOTECHNOLOGY | 1995年 / 6卷 / 06期

关键词：

D O I：

10.1016/0958-1669(95)80113-8

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

After nearly 20 years in the clinic, the benefits of interferon-beta treatment in specific disease states are being recognized increasingly. Two major clinical studies completed within the past two years have firmly established the use of this drug in the treatment of multiple sclerosis. Its therapeutic activity in several indications, including acute and chronic viral hepatitis, has also been demonstrated; however, the general use of interferon-beta in these settings awaits the results of ongoing studies and the development of practical dosing regimens.

引用

页码：688 / 691

页数：4

共 26 条

[1] DIFFERENTIAL TYROSINE PHOSPHORYLATION OF THE IFNAR CHAIN OF THE TYPE-I INTERFERON RECEPTOR AND OF AN ASSOCIATED SURFACE PROTEIN IN RESPONSE TO IFN-ALPHA AND IFN-BETA [J].

ABRAMOVICH, C ;

SHULMAN, LM ;

RATOVITSKI, E ;

HARROCH, S ;

TOVEY, M ;

EID, P ;

REVEL, M .

EMBO JOURNAL, 1994, 13 (24) :5871-5877

[2]

Boccia S., 1993, Journal of Hepatology, V18, pS97

[3]

CAPALBO M, 1994, ITAL J GASTROENTEROL, V26, P238

[4] JAK-STAT PATHWAYS AND TRANSCRIPTIONAL ACTIVATION IN RESPONSE TO IFNS AND OTHER EXTRACELLULAR SIGNALING PROTEINS [J].

DARNELL, JE ;

KERR, IM ;

STARK, GR .

SCIENCE, 1994, 264 (5164) :1415-1421

[5] INTRAMUSCULAR INTERFERON-BETA TREATMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA-II ASSOCIATED WITH HUMAN PAPILLOMAVIRUS INFECTION [J].

DEALOYSIO, D ;

MILIFFI, L ;

IANNICELLI, T ;

PENACCHIONI, P ;

BOTTIGLIONI, F .

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1994, 73 (05) :420-424

[6]

DUQUETTE P, 1995, NEUROLOGY, V45, P1277

[7] INTERFERON BETA-1B IS EFFECTIVE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - CLINICAL-RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].

DUQUETTE, P ;

GIRARD, M ;

DESPAULT, L ;

DUBOIS, R ;

KNOBLER, RL ;

LUBLIN, FD ;

KELLEY, L ;

FRANCIS, GS ;

LAPIERRE, Y ;

ANTEL, J ;

FREEDMAN, M ;

HUM, S ;

GREENSTEIN, JI ;

MISHRA, B ;

MULDOON, J ;

WHITAKER, JN ;

EVANS, BK ;

LAYTON, B ;

SIBLEY, WA ;

LAGUNA, J ;

KRIKAWA, J ;

PATY, DW ;

OGER, JJ ;

KASTRUKOFF, LF ;

MOORE, GRW ;

HASHIMOTO, SA ;

MORRISON, W ;

NELSON, J ;

GOODIN, DS ;

MASSA, SM ;

GUTTERIDGE, E ;

ARNASON, BGW ;

NORONHA, A ;

REDER, AT ;

MARTIA, R ;

EBERS, GC ;

RICE, GPA ;

LESAUX, J ;

JOHNSON, KP ;

PANITCH, HS ;

BEVER, CT ;

CONWAY, K ;

WALLENBERG, JC ;

BEDELL, L ;

VANDENNOORT, S ;

WEINSHENKER, B ;

WEISS, W ;

REINGOLD, S ;

PACHNER, A ;

TAYLOR, W .

NEUROLOGY, 1993, 43 (04) :655-661

[8]

Gandin C., 1993, Journal of Hepatology, V18, pS121

[9] CYTOKINE THERAPEUTICS - LESSONS FROM INTERFERON-ALPHA [J].

GUTTERMAN, JU .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (04) :1198-1205

[10]

HAUSER SL, 1993, HARRISONS PRINCIPLES, P2287

← 1 2 3 →